| Mrs Jackalyn Lee Mitchell, RN, OGNP | |
|
612 College St, Jacksonville, NC 28540-5311 | |
| (910) 347-2154 | |
| (910) 347-0728 |
| Full Name | Mrs Jackalyn Lee Mitchell |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist - Perinatal |
| Location | 612 College St, Jacksonville, North Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801964978 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Jackalyn Lee Mitchell, RN, OGNP 612 College St, Jacksonville, NC 28540-5311 Ph: (910) 347-2154 | Mrs Jackalyn Lee Mitchell, RN, OGNP 612 College St, Jacksonville, NC 28540-5311 Ph: (910) 347-2154 |
News Archive
The fifth leading cause of cancer in the United States, lymphoma is made up of more than 40 rare and highly diverse diseases that target the body's lymphatic system. Lymphomas include both one of the fastest growing cancers - Burkitt's lymphoma, which can double in size in as little as a day - and one of the slowest, chronic lymphocytic leukemia (CLL).
A German research team has examined data on supply and demand for blood transfusions against a computer simulation of an influenza pandemic, and discovered that a severe pandemic scenario could quickly lead to a deficit of up to 96,000 red blood cell (RBC) transfusion units in Germany alone, creating potentially fatal outcomes. Their study is published today in the journal TRANSFUSION.
New research at Rhode Island Hospital has identified a treatment in animal models for glioblastomas - deadly brain tumors which, once diagnosed, offer a poor prognosis and relatively short life expectancy.
For the past five years, the Douglas Mental Health University Institute has been offering the Mini-Psych School, the only public education program of its kind in Quebec. This year, the program will be focussing on mental health in children and youth.
Cannabis Science Inc. (NASD OTCBB: CBIS) an emerging pharmaceutical cannabis company, is pleased to report that it will be featured on two broadcast radio shows beginning tomorrow with Stu Taylor and the "Equity Strategies Show". Mr. Taylor will interview Cannabis Science Inc., President & CEO, Dr. Robert Melamede Ph.D., discussing the Company's strategies with its FDA Drug approval programs, the Company's progress to date with its critical drug release programs, and future planning for subsequent drug releases through additional Federal and State government agencies.
› Verified 2 days ago